Enliven Therapeutics Balance Sheet (2019-2026) | ELVN

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Accumulated Depreciation (Quarter)
0.23M0.37M0.44M0.52M0.59M0.67M0.75M0.83M0.91M0.92M0.99M1.07M1.14M0.23M0.24M
Assets
Current Assets
Cash & Equivalents (Quarter)
48.04M75.30M48.31M99.88M92.46M86.16M75.54M292.10M125.72M73.85M100.14M149.16M96.87M100.62M124.12M101.70M119.44M101.73M98.90M132.18M
Prepaid Assets (Quarter)
4.59M3.16M2.42M5.63M3.92M2.80M2.22M5.90M5.31M5.13M2.95M6.64M5.68M5.11M4.63M4.76M5.12M5.12M12.26M10.74M
Current Assets (Quarter)
71.36M106.00M92.70M78.53M64.26M59.10M77.75M298.00M283.18M268.61M266.15M337.20M318.13M297.00M318.13M294.32M495.62M482.68M474.88M463.14M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.30M0.28M0.25M0.59M0.10M0.89M0.85M0.87M0.81M0.74M0.68M0.63M0.55M0.46M0.40M0.46M0.40M0.03M0.02M
Other Non-Current Assets (Quarter)
0.17M0.17M0.17M0.17M0.17M0.05M0.05M0.05M4.09M4.09M7.56M7.24M7.17M7.20M7.24M7.10M0.66M1.19M
Non-Current Assets (Quarter)
1.11M1.03M0.95M3.07M0.41M5.54M4.86M5.33M5.43M5.72M5.58M8.92M8.43M7.63M8.25M8.27M8.19M1.29M1.72M
Assets (Quarter)
72.47M107.03M93.65M81.60M64.67M59.10M83.30M302.87M288.50M274.04M271.87M342.78M327.04M305.43M325.76M302.57M503.89M490.88M476.17M464.85M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.63M2.48M2.36M1.88M1.14M0.77M3.44M5.86M2.84M1.49M0.53M2.73M1.08M1.02M1.34M1.56M2.35M1.43M2.16M1.64M
Payables (Quarter)
2.63M2.48M2.36M1.88M1.14M0.77M3.44M5.86M2.84M1.49M0.53M2.73M1.08M1.02M1.34M1.56M2.35M1.43M2.16M1.64M
Accumulated Expenses (Quarter)
4.09M4.46M4.60M4.83M1.72M1.05M6.28M1.04M6.30M10.59M3.33M12.30M2.08M3.48M4.61M12.41M12.86M13.22M14.41M9.85M
Other Accumulated Expenses (Quarter)
0.45M0.55M0.34M0.37M0.36M0.45M0.29M0.22M0.20M0.15M0.06M0.09M0.35M0.11M
Current Leases (Quarter)
0.25M0.25M0.25M0.51M0.45M0.32M0.33M0.33M0.34M0.25M0.17M0.09M0.36M0.38M0.39M0.40M0.30M
Current Taxes (Quarter)
0.23M
Total Current Liabilities (Quarter)
6.97M7.19M7.21M7.22M3.30M1.82M9.71M10.94M9.15M12.08M25.89M25.03M22.11M17.03M15.91M13.97M15.21M14.65M16.57M11.49M
Non-Current Liabilities
Non-Current Deffered Revenue (Quarter)
3.98M0.52M0.56M0.56M0.56M0.56M0.56M0.22M0.22M0.22M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)
0.53M0.47M0.41M1.97M
Other Non-Current Liabilities (Quarter)
0.66M0.51M0.36M0.21M0.07M0.03M0.01M0.30M0.20M0.10M
Total Non-Current Liabilities (Quarter)
9.71M10.94M9.15M12.08M25.89M25.03M22.11M17.03M15.91M13.97M15.21M14.65M
Total Liabilities (Quarter)
7.50M7.65M7.62M9.19M3.30M1.82M10.37M11.45M9.51M12.29M25.96M25.07M22.11M17.03M15.91M14.27M15.41M14.75M16.57M11.49M
Shareholder's Equity
Common Equity (Quarter)
64.97M99.37M-42.89M-50.61M-58.71M-68.10M-76.83M291.42M278.99M261.75M245.91M317.71M304.93M288.40M309.85M288.30M488.47M476.12M459.60M453.37M
Shareholder's Equity (Quarter)
64.97M99.37M-42.89M-50.61M-58.71M-68.10M-76.83M291.42M278.99M261.75M245.91M317.71M304.93M288.40M309.85M288.30M488.47M476.12M459.60M453.37M
Liabilities and Shareholders Equity (Quarter)
72.47M107.03M93.65M81.60M64.67M59.10M83.30M302.87M288.50M274.04M271.87M342.78M327.04M305.43M325.76M302.57M503.89M490.88M476.17M464.85M
Retained Earnings (Quarter)
-119.53M-133.20M-0.02M-162.14M-173.59M-0.00M-82.86M-97.59M-114.31M-135.10M0.14M-0.05M-197.10M-220.30M0.06M-0.02M-297.35M-317.50M-347.17M-0.38M
Preferred Shares (Quarter)
149.75M
Treasury Shares (Quarter)
0.10M0.43M0.24M0.21M0.04M0.03M0.02M0.08M0.10M0.09M0.09M0.08M0.10M0.09M0.08M0.08M0.32M
Shares Outstanding (Quarter)
17.91M26.28M3.44M61.73M61.73M61.73M61.73M41.11M41.15M41.20M41.29M46.78M47.17M47.25M48.94M49.04M59.23M59.26M59.44M60.89M